Developer docs
API playgroundTry for free, no card

Search company profiles

3D Biotek

Full company profile

uuid000hgok

Namestring
3D Biotek
Legal namestring
3D Biotek LLC
Websiteurl
3dbiotek.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

3D Biotek LLC is a New Jersey-based biotechnology company founded in April 2007 that designs, manufactures, and sells novel 3D cell culture devices and bioreactor systems for research and biomedical applications. The company's core offerings are built on a proprietary Precision 3D Micro-Fabrication Technology platform that produces porous polymer scaffolds — 3D Insert-PCL (biodegradable polycaprolactone) and 3D Insert-PS (polystyrene) — with 100% open porosity, well-defined pore sizes, and batch-to-batch reproducibility. These scaffolds integrate with the 3D Perfusion Bioreactor for dynamic culture, and the company also sells HA Discs for bone research and the 3D Cell Expansion System (3D-CES), an integrated bioreactor/incubator registered with the US FDA as a Class I medical device capable of producing up to 500 million anchorage-dependent cells per production run in 14-18 days. Contract lab services and custom manufacturing services (including medical device prototyping and stent fabrication) round out the portfolio.

The company serves academic researchers, pharmaceutical drug discovery groups, and biotech firms working in stem cell expansion, tissue engineering, cancer research, and drug screening. It is US FDA registered and ISO-13485-2016 certified (since May 2019), with a GMP facility established in 2017. 3D Biotek distributes products through a global network of regional distributors covering North America, Europe, Asia, and Africa, complemented by direct e-commerce via 3dbiotekstore.com and conference-driven demand generation. Following a 100% equity acquisition by Hong Kong-based Mega Hill Corporation Limited in October 2015, the company has continued to operate from New Jersey (currently in Warren, NJ) with a 1-10 employee headcount, supplemented by multiple federal and state grants (NSF, SBIR/NIH, Edison, NJCST) over its history.

Short descriptiontext

3D Biotek LLC is a New Jersey-based biotech company that designs and sells proprietary 3D porous polymer scaffolds, perfusion bioreactors, and a large-scale cell expansion system for academic researchers, pharmaceutical firms, and biotech companies in stem cell, tissue engineering, and drug discovery applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNorth Brunswick, United States
HQ citystring
North Brunswick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D cell culture devices, tissue engineering scaffolds, stem cell expansion systems, biomedical microfabrication, in vitro drug screening tools
Industry3 codes
PRIMARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYIMAAAFAI
Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
Industrials, Manufacturing & Construction/3D Printing/Rapid Prototyping & Product Development (Additive)
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing33911
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
3D Cell Culture Devices and Biomedical Research Tools
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
13D Cell Culture Products
TypeHardware Sales
Description

Sale of 3D Insert scaffolds (PCL and PS), HA Discs, 3D Bioreactors, and 3D Cell Expansion Systems to research institutions, pharmaceutical companies, and biotech firms.

3dbiotek.com
2Contract Lab Services
TypeProfessional Services
Description

Custom laboratory services including custom design, product prototyping, consulting, and regulatory filing support. Services include 3D toxicity assays for cancer and drug screening using various cell lines.

3dbiotek.com
3Manufacturing Services
TypeProfessional Services
Description

Custom design and fabrication of 3D cell culture/tissue engineering scaffolds, medical device prototyping, and Rapid Stent Fabrication System for bioabsorbable porous tubular structures.

3dbiotek.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
13D Insert
Description

Series of novel 3D porous scaffolds for drug screening, stem cell research, and tissue engineering.

3dbiotek.com
+1 more record
Core offering1 text field

3D Biotek manufactures and sells novel 3D porous scaffold inserts (PCL and PS), the 3D Cell Expansion System (3D-CES) bioreactor/incubator, 3D Perfusion Bioreactors, and HA Discs for 3D cell culture, stem cell expansion, and tissue engineering research. It also provides Contract Lab Services and custom Manufacturing Services for medical device prototyping and tissue engineering scaffolds.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 200-300 million cells expanded per chamber in 14-18 days
+2 more records
Product overview1 text field

3D Biotek offers a portfolio of 3D cell culture products and biomedical manufacturing services. The core product line consists of 3D Insert scaffolds (available in both biodegradable PCL and non-biodegradable PS materials), which serve as the foundational 3D cell culture platform. These scaffolds integrate with the 3D Perfusion Bioreactor for dynamic culture applications. The 3D Cell Expansion System (3D-CES) represents the company's integrated bioreactor/incubator system for large-scale stem cell expansion. HA Discs address bone research applications. The company also provides Contract Lab Services and Manufacturing Services for custom scaffold fabrication and medical device prototyping. The Precision 3D Micro-Fabrication Technology platform underpins the entire product portfolio.

Product and service8 records
13D Insert-PCL
Category3D Cell Culture Scaffolds
Description

3D porous scaffolds fabricated from polycaprolactone (PCL), a biodegradable polymer used in FDA-approved implants. Prepackaged into tissue culture plates ranging from 6-well to 96-well formats, terminally sterilized by gamma radiation. Designed for researchers in drug screening, stem cell research, and tissue engineering who need biodegradable 3D culture substrates.

23D Insert-PS
Category3D Cell Culture Scaffolds
Description

3D porous scaffolds fabricated from polystyrene, the same material as traditional tissue culture plates. Prepackaged into tissue culture plates (6-well to 96-well), terminally sterilized, and transparent for direct monitoring of cell growth under inverted microscope. Targeted at researchers needing non-biodegradable, microscope-compatible 3D culture substrates.

33D Cell Expansion System (3D-CES)
Category3D Cell Expansion Bioreactor System
Description

Integrated bioreactor/incubator system for large-scale expansion of anchorage-dependent cells in a 3D micro-environment. Features 2-chamber design allowing expansion of up to 500 million cells per production run in approximately 14-18 days. Registered with US FDA as a Class I medical device. Designed for bio-banking, stem cell therapy, and exosome production applications.

43D Perfusion Bioreactor
Category3D Perfusion Bioreactor
Description

3D perfusion bioreactor with multiple independent autoclavable polycarbonate chambers designed to work with 3D Insert scaffolds (24-well, 12-well, 6-well sizes). Media is perfused through porous scaffold structure using a peristaltic pump for dynamic cell culture. Targeted at researchers needing dynamic perfusion culture for tissue engineering and drug screening.

5HA Disc
CategoryBone Research Substrate
Description

Hydroxyapatite discs made from 100% synthetic material for bone-related research including osteoporosis, bone matrix mineralization, tissue calcification, and bone defect repair. Pre-sterilized and individually packaged using gamma radiation. Targeted at researchers in bone biology and orthopedic tissue engineering.

63D Cell Transfection Kit
Category3D Cell Culture Reagent Kit
Description

Product launched in April 2010 for conducting 3D cell transfection experiments, introduced alongside the BioCellChallenge partnership.

7Contract Lab Services
CategoryContract Research Services
Description

Custom laboratory services including design, product prototyping (medical devices, tissue engineering), and regulatory consulting. Includes 3D toxicity assays for cancer and drug screening using cell lines such as MCF-7, HepG2, Fibroblasts, Keratinocytes, Osteoblasts, and Stem Cells. Targeted at pharmaceutical and biotech R&D teams needing outsourced 3D cell culture expertise.

8Manufacturing Services
CategoryCustom Contract Manufacturing
Description

Custom design and fabrication of 3D cell culture and tissue engineering scaffolds using patented 3D Precision Micro-Fabrication Technology. Also includes medical device prototyping and the Rapid Stent Fabrication (RSF) System for bioabsorbable porous tubular structures. Targeted at medical device companies and tissue engineering groups needing custom scaffold manufacturing.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

Collaborative research partnership for NSF Phase I Grant awarded in 2014 for developing biomimetic nanofiber coating on dental implants for gingival regeneration.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2011-12-01
Description

3D Biotek and KIYATEC formed a strategic partnership in December 2011 to launch synergistic 3D cell culture products. The collaboration introduced preassembled, single-use disposable scaffolds with plasticware preloads as an industry first.

3BioCellChallenge
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2010-04-01
Description

Partnership with BioCellChallenge SAS for distribution of 3D Biotek products and launch of 3D Cell Transfection Kit in April 2010.

3dbiotek.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

US-based organ-on-chip technology company targeting pharmaceutical drug discovery. Adjacent competitor to 3D Biotek in 3D cell culture for drug screening, with a different technological approach using microfluidic chips.

TypeEmerging player
Description

Swedish company specializing in bioprinting technology and 3D cell culture products. Comparable to 3D Biotek in 3D culture and tissue engineering, with additional focus on bioprinters and bioinks.

TypeDirect peer
Description

Swiss company specializing in 3D cell culture technology, organoids, and microtissue-based drug discovery platforms. Most directly comparable to 3D Biotek in serving stem cell and drug discovery researchers with 3D culture tools.

4CN Bio
TypeEmerging player
Description

UK-based organ-on-chip and 3D cell culture company providing single- and multi-organ microphysiological systems. Adjacent competitor to 3D Biotek in 3D cell culture for drug discovery applications.

TypeDirect peer
Description

Dutch company providing organ-on-chip and 3D tissue models for drug discovery. Comparable to 3D Biotek in targeting pharmaceutical researchers with 3D culture platforms, though focused on microfluidic organ-on-chip rather than porous scaffolds.

6Corning Life Sciences
TypeBroad incumbent
Description

Major life science tools manufacturer offering a broad portfolio of cell culture products including spheroid microplates and Corning Matrigel matrix. Competes with 3D Biotek in 3D cell culture but as part of a much wider catalog rather than a 3D-focused specialist.

TypeBroad incumbent
Description

Major cell and gene therapy manufacturing services provider with bioreactor and cell expansion capabilities. Comparable to 3D Biotek in the cell expansion and tissue engineering space, but operates at significantly larger scale as a CDMO.

TypeDirect peer
Description

Japan-based provider of 3D cell culture and stem cell research tools, including scaffold-based products for regenerative medicine and drug screening. Direct overlap with 3D Biotek in 3D culture products for stem cell and tissue engineering applications.

TypeEmerging player
Description

US-based 3D bioprinting company developing functional human tissues for drug discovery and therapeutic applications. Comparable to 3D Biotek in tissue engineering and 3D cell culture space, with bioprinting-centric approach.

TypeBroad incumbent
Description

Global life science tools leader with extensive cell culture, bioreactor, and 3D culture product lines (Gibco, Nunc). Competes with 3D Biotek through broad portfolio and bundled offerings to pharma and academic customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

3D Biotek

3D Cell Culture Devices and Biomedical Research Tools3dbiotek.com

3D Biotek LLC is a New Jersey-based biotech company that designs and sells proprietary 3D porous polymer scaffolds, perfusion bioreactors, and a large-scale cell expansion system for academic researchers, pharmaceutical firms, and biotech companies in stem cell, tissue engineering, and drug discovery applications.

What 3D Biotek does

3D Biotek LLC is a New Jersey-based biotechnology company founded in April 2007 that designs, manufactures, and sells novel 3D cell culture devices and bioreactor systems for research and biomedical applications. The company's core offerings are built on a proprietary Precision 3D Micro-Fabrication Technology platform that produces porous polymer scaffolds — 3D Insert-PCL (biodegradable polycaprolactone) and 3D Insert-PS (polystyrene) — with 100% open porosity, well-defined pore sizes, and batch-to-batch reproducibility. These scaffolds integrate with the 3D Perfusion Bioreactor for dynamic culture, and the company also sells HA Discs for bone research and the 3D Cell Expansion System (3D-CES), an integrated bioreactor/incubator registered with the US FDA as a Class I medical device capable of producing up to 500 million anchorage-dependent cells per production run in 14-18 days. Contract lab services and custom manufacturing services (including medical device prototyping and stent fabrication) round out the portfolio.

The company serves academic researchers, pharmaceutical drug discovery groups, and biotech firms working in stem cell expansion, tissue engineering, cancer research, and drug screening. It is US FDA registered and ISO-13485-2016 certified (since May 2019), with a GMP facility established in 2017. 3D Biotek distributes products through a global network of regional distributors covering North America, Europe, Asia, and Africa, complemented by direct e-commerce via 3dbiotekstore.com and conference-driven demand generation. Following a 100% equity acquisition by Hong Kong-based Mega Hill Corporation Limited in October 2015, the company has continued to operate from New Jersey (currently in Warren, NJ) with a 1-10 employee headcount, supplemented by multiple federal and state grants (NSF, SBIR/NIH, Edison, NJCST) over its history.

3D Biotek firmographics

Firmographics
Name
3D Biotek
Legal name
3D Biotek LLC
Website
https://3dbiotek.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
3D Biotek LLC is a New Jersey-based biotech company that designs and sells proprietary 3D porous polymer scaffolds, perfusion bioreactors, and a large-scale cell expansion system for academic researchers, pharmaceutical firms, and biotech companies in stem cell, tissue engineering, and drug discovery applications.
Ownership category
akta.pro rank

3D Biotek industry classification

Industry
Product category
3D Cell Culture Devices and Biomedical Research Tools
NAICS
Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYIMAAAFAI
Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
Industrials, Manufacturing & Construction/3D Printing/Rapid Prototyping & Product Development (Additive)

Keywords

  • 3D cell culture devices
  • Tissue engineering scaffolds
  • Stem cell expansion systems
  • Biomedical microfabrication
  • In vitro drug screening tools

Where 3D Biotek is headquartered

Location

Headquarters

HQ city
North Brunswick
HQ country
United States
HQ region
North America

Offices2 records

Markets served

3D Biotek business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales

Revenue model

  1. 3D Cell Culture Products: Sale of 3D Insert scaffolds (PCL and PS), HA Discs, 3D Bioreactors, and 3D Cell Expansion Systems to research institutions, pharmaceutical companies, and biotech firms.
  2. Contract Lab Services: Custom laboratory services including custom design, product prototyping, consulting, and regulatory filing support. Services include 3D toxicity assays for cancer and drug screening using various cell lines.
  3. Manufacturing Services: Custom design and fabrication of 3D cell culture/tissue engineering scaffolds, medical device prototyping, and Rapid Stent Fabrication System for bioabsorbable porous tubular structures.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

3D Biotek product offering

Product offering

Core offering

3D Biotek manufactures and sells novel 3D porous scaffold inserts (PCL and PS), the 3D Cell Expansion System (3D-CES) bioreactor/incubator, 3D Perfusion Bioreactors, and HA Discs for 3D cell culture, stem cell expansion, and tissue engineering research. It also provides Contract Lab Services and custom Manufacturing Services for medical device prototyping and tissue engineering scaffolds.

Product overview

3D Biotek offers a portfolio of 3D cell culture products and biomedical manufacturing services. The core product line consists of 3D Insert scaffolds (available in both biodegradable PCL and non-biodegradable PS materials), which serve as the foundational 3D cell culture platform. These scaffolds integrate with the 3D Perfusion Bioreactor for dynamic culture applications. The 3D Cell Expansion System (3D-CES) represents the company's integrated bioreactor/incubator system for large-scale stem cell expansion. HA Discs address bone research applications. The company also provides Contract Lab Services and Manufacturing Services for custom scaffold fabrication and medical device prototyping. The Precision 3D Micro-Fabrication Technology platform underpins the entire product portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • 3D Insert: Series of novel 3D porous scaffolds for drug screening, stem cell research, and tissue engineering.
  • 3D Cell Expansion System (3D-CES)

Products and services

  • 3D Insert-PCL 3D porous scaffolds fabricated from polycaprolactone (PCL), a biodegradable polymer used in FDA-approved implants. Prepackaged into tissue culture plates ranging from 6-well to 96-well formats, terminally sterilized by gamma radiation. Designed for researchers in drug screening, stem cell research, and tissue engineering who need biodegradable 3D culture substrates.
  • 3D Insert-PS 3D porous scaffolds fabricated from polystyrene, the same material as traditional tissue culture plates. Prepackaged into tissue culture plates (6-well to 96-well), terminally sterilized, and transparent for direct monitoring of cell growth under inverted microscope. Targeted at researchers needing non-biodegradable, microscope-compatible 3D culture substrates.
  • 3D Cell Expansion System (3D-CES) Integrated bioreactor/incubator system for large-scale expansion of anchorage-dependent cells in a 3D micro-environment. Features 2-chamber design allowing expansion of up to 500 million cells per production run in approximately 14-18 days. Registered with US FDA as a Class I medical device. Designed for bio-banking, stem cell therapy, and exosome production applications.
  • 3D Perfusion Bioreactor 3D perfusion bioreactor with multiple independent autoclavable polycarbonate chambers designed to work with 3D Insert scaffolds (24-well, 12-well, 6-well sizes). Media is perfused through porous scaffold structure using a peristaltic pump for dynamic cell culture. Targeted at researchers needing dynamic perfusion culture for tissue engineering and drug screening.
  • HA Disc Hydroxyapatite discs made from 100% synthetic material for bone-related research including osteoporosis, bone matrix mineralization, tissue calcification, and bone defect repair. Pre-sterilized and individually packaged using gamma radiation. Targeted at researchers in bone biology and orthopedic tissue engineering.
  • 3D Cell Transfection Kit Product launched in April 2010 for conducting 3D cell transfection experiments, introduced alongside the BioCellChallenge partnership.
  • Contract Lab Services Custom laboratory services including design, product prototyping (medical devices, tissue engineering), and regulatory consulting. Includes 3D toxicity assays for cancer and drug screening using cell lines such as MCF-7, HepG2, Fibroblasts, Keratinocytes, Osteoblasts, and Stem Cells. Targeted at pharmaceutical and biotech R&D teams needing outsourced 3D cell culture expertise.
  • Manufacturing Services Custom design and fabrication of 3D cell culture and tissue engineering scaffolds using patented 3D Precision Micro-Fabrication Technology. Also includes medical device prototyping and the Rapid Stent Fabrication (RSF) System for bioabsorbable porous tubular structures. Targeted at medical device companies and tissue engineering groups needing custom scaffold manufacturing.

Quantifiable outcome

  • 200-300 million cells expanded per chamber in 14-18 days
  • +2 more outcomes

Companies that use 3D Biotek

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

3D Biotek technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

3D Biotek partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

  • Stevens Institute of TechnologyminorStrategic or Co-development Partner · 1 January 2014Collaborative research partnership for NSF Phase I Grant awarded in 2014 for developing biomimetic nanofiber coating on dental implants for gingival regeneration.
  • KIYATECminorStrategic or Co-development Partner · 1 December 20113D Biotek and KIYATEC formed a strategic partnership in December 2011 to launch synergistic 3D cell culture products. The collaboration introduced preassembled, single-use disposable scaffolds with plasticware preloads as an industry first.
  • BioCellChallengeminorChannel Partner/ Reseller/ Distributor · 1 April 2010Partnership with BioCellChallenge SAS for distribution of 3D Biotek products and launch of 3D Cell Transfection Kit in April 2010.

Scale indicators2 records

Recent moves9 records

Expansion highlights6 records

3D Biotek competitors and assessment

Company assessment

Emerging players

  • Emulate: US-based organ-on-chip technology company targeting pharmaceutical drug discovery. Adjacent competitor to 3D Biotek in 3D cell culture for drug screening, with a different technological approach using microfluidic chips.
  • Bico (formerly CELLINK): Swedish company specializing in bioprinting technology and 3D cell culture products. Comparable to 3D Biotek in 3D culture and tissue engineering, with additional focus on bioprinters and bioinks.
  • CN Bio: UK-based organ-on-chip and 3D cell culture company providing single- and multi-organ microphysiological systems. Adjacent competitor to 3D Biotek in 3D cell culture for drug discovery applications.
  • Organovo: US-based 3D bioprinting company developing functional human tissues for drug discovery and therapeutic applications. Comparable to 3D Biotek in tissue engineering and 3D cell culture space, with bioprinting-centric approach.

Direct peers

  • InSphero: Swiss company specializing in 3D cell culture technology, organoids, and microtissue-based drug discovery platforms. Most directly comparable to 3D Biotek in serving stem cell and drug discovery researchers with 3D culture tools.
  • Mimetas: Dutch company providing organ-on-chip and 3D tissue models for drug discovery. Comparable to 3D Biotek in targeting pharmaceutical researchers with 3D culture platforms, though focused on microfluidic organ-on-chip rather than porous scaffolds.
  • REPROCELL: Japan-based provider of 3D cell culture and stem cell research tools, including scaffold-based products for regenerative medicine and drug screening. Direct overlap with 3D Biotek in 3D culture products for stem cell and tissue engineering applications.

Broad incumbents

  • Corning Life Sciences: Major life science tools manufacturer offering a broad portfolio of cell culture products including spheroid microplates and Corning Matrigel matrix. Competes with 3D Biotek in 3D cell culture but as part of a much wider catalog rather than a 3D-focused specialist.
  • Lonza: Major cell and gene therapy manufacturing services provider with bioreactor and cell expansion capabilities. Comparable to 3D Biotek in the cell expansion and tissue engineering space, but operates at significantly larger scale as a CDMO.
  • Thermo Fisher Scientific: Global life science tools leader with extensive cell culture, bioreactor, and 3D culture product lines (Gibco, Nunc). Competes with 3D Biotek through broad portfolio and bundled offerings to pharma and academic customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

3D Biotek social profiles

Digital presence

3D Biotek compliance and trust

Trust signal

Compliance2 records

3D Biotek financial estimates

Financial estimate

Revenue estimate

Valuation estimate

3D Biotek leadership team

Management profile

Number of profiles

Profiles4 records

3D Biotek funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

3D Biotek M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3D Biotek

What does 3D Biotek do?

3D Biotek manufactures and sells novel 3D porous scaffold inserts (PCL and PS), the 3D Cell Expansion System (3D-CES) bioreactor/incubator, 3D Perfusion Bioreactors, and HA Discs for 3D cell culture, stem cell expansion, and tissue engineering research. It also provides Contract Lab Services and custom Manufacturing Services for medical device prototyping and tissue engineering scaffolds.

Is 3D Biotek a public or private company?

3D Biotek is a private company. It is classified as corporate owned and is currently operating.

When was 3D Biotek founded?

3D Biotek was founded in 2007. It employs 1 to 10 people.

Where is 3D Biotek based?

3D Biotek is headquartered in North Brunswick, United States, in the North America region.

How does 3D Biotek make money?

Three revenue lines are on record. 3D Cell Culture Products are the primary driver. The others are contract Lab Services and manufacturing Services.

Who are 3D Biotek's main competitors?

Emerging players on record are Emulate, Bico (formerly CELLINK), CN Bio and Organovo. Direct peers are InSphero, Mimetas and REPROCELL. Broad incumbents are Corning Life Sciences, Lonza and Thermo Fisher Scientific.

Does 3D Biotek have an API?

No public API is recorded for 3D Biotek.

What industry is 3D Biotek in?

3D Biotek's product category is 3D Cell Culture Devices and Biomedical Research Tools. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 33911 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals